Sarepta Therapeutics (SRPT) Intangibles (2010 - 2026)

Sarepta Therapeutics' Intangibles history runs 17 years deep, the most recent figure standing at $31.4 million for Q1 2026.

• In Q1 2026, Intangibles rose 19.79% year-over-year to $31.4 million; the TTM figure through Mar 2026 stood at $31.4 million (up 19.79% YoY), while the FY2025 annual figure was $28.9 million, up 7.67% from the prior year.
• Intangibles was $31.4 million for Q1 2026 at Sarepta Therapeutics, up from $28.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $31.4 million in Q1 2026 to a low of $7.2 million in Q1 2023.
• Historically, Intangibles has averaged $21.9 million across 5 years, with a median of $26.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Intangibles plunged 64.35% in 2022, then soared 301.86% in 2024.
• A 5-year view of Intangibles shows it stood at $7.6 million in 2022, then surged by 203.51% to $23.0 million in 2023, then rose by 16.9% to $26.9 million in 2024, then climbed by 7.67% to $28.9 million in 2025, then advanced by 8.41% to $31.4 million in 2026.
• The last three Intangibles figures came in at $31.4 million (Q1 2026), $28.9 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.